Suarez, Jennifer G.
HRN: 27-11-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/11/2025
07/18/2025
IV
500 Mg
Q8
AGE
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines